No abstract available
Keywords:
BRCA1/2 mutation; Biomarker; PARP inhibitor; prostate cancer; stratification; targeted therapy.
MeSH terms
-
Antineoplastic Agents / pharmacology*
-
Humans
-
Male
-
Neoplasm Metastasis
-
Poly(ADP-ribose) Polymerase Inhibitors / pharmacology*
-
Poly(ADP-ribose) Polymerases / drug effects
-
Poly(ADP-ribose) Polymerases / metabolism
-
Prostatic Neoplasms / drug therapy*
-
Prostatic Neoplasms / pathology
-
Survival Rate
Substances
-
Antineoplastic Agents
-
Poly(ADP-ribose) Polymerase Inhibitors
-
Poly(ADP-ribose) Polymerases